Paul Cuddon
Stock Analyst at Deutsche Bank
(3.49)
# 2,172
Out of 4,334 analysts
21
Total ratings
55.6%
Success rate
15%
Average return
Main Sectors:
Stocks Rated by Paul Cuddon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: ONT Oxford Nanopore Technologies plc | Reiterated: Buy | $2.1 → $225 | $129.40 | +73.88% | 6 | Jan 22, 2026 | |
| LON: SYNC Syncona Limited | Maintained: Buy | $1.7 | $98.00 | -98.27% | 1 | Jun 20, 2025 | |
| LON: HIK Hikma Pharmaceuticals PLC | Maintained: Buy | $2,750 → $31 | $1,459.00 | n/a | 3 | Nov 25, 2024 | |
| MXCT MaxCyte | Upgraded: Buy | $330 → $500 | $1.04 | n/a | 2 | Oct 10, 2024 | |
| LON: OXB Oxford Biomedica plc | Maintained: Hold | $250 → $380 | $618.00 | n/a | 2 | Sep 24, 2024 | |
| AIM: UPR Uniphar plc | Reiterated: Buy | $310 | $388.00 | n/a | 2 | Sep 4, 2024 | |
| AIM: AVCT Avacta Group Plc | Initiated Coverage: Hold | $40 | $79.00 | n/a | 2 | Jun 19, 2024 | |
| AIM: NIOX NIOX Group Plc | Initiated Coverage: Hold | $250 | $59.20 | n/a | 1 | May 3, 2024 | |
| AIM: CREO Creo Medical Group PLC | Maintained: Buy | $80 | $14.50 | n/a | 1 | May 3, 2024 | |
| LON: IPO IP Group Plc | Initiated Coverage: Buy | $100 | $67.10 | n/a | 1 | May 3, 2024 |
Oxford Nanopore Technologies plc
Jan 22, 2026
Reiterated: Buy
Price Target: $2.1 → $225
Current: $129.40
Upside: +73.88%
Syncona Limited
Jun 20, 2025
Maintained: Buy
Price Target: $1.7
Current: $98.00
Upside: -98.27%
Hikma Pharmaceuticals PLC
Nov 25, 2024
Maintained: Buy
Price Target: $2,750 → $31
Current: $1,459.00
Upside: n/a
MaxCyte
Oct 10, 2024
Upgraded: Buy
Price Target: $330 → $500
Current: $1.04
Upside: n/a
Oxford Biomedica plc
Sep 24, 2024
Maintained: Hold
Price Target: $250 → $380
Current: $618.00
Upside: n/a
Uniphar plc
Sep 4, 2024
Reiterated: Buy
Price Target: $310
Current: $388.00
Upside: n/a
Avacta Group Plc
Jun 19, 2024
Initiated Coverage: Hold
Price Target: $40
Current: $79.00
Upside: n/a
NIOX Group Plc
May 3, 2024
Initiated Coverage: Hold
Price Target: $250
Current: $59.20
Upside: n/a
Creo Medical Group PLC
May 3, 2024
Maintained: Buy
Price Target: $80
Current: $14.50
Upside: n/a
IP Group Plc
May 3, 2024
Initiated Coverage: Buy
Price Target: $100
Current: $67.10
Upside: n/a